Towards the clinical translation of a silver sulfide nanoparticle contrast agent: large scale production with a highly parallelized microfluidic chip
These studies have identified a promising method for the large-scale production of Ag<sub>2</sub>S-NP, paving the way for eventual clinical translation.
Authors
- David P. Cormode (ORCID: https://orcid.org/0000-0002-8391-9500)
- Michael J. Siedlik
- Sarah J. Shepherd (ORCID: https://orcid.org/0000-0002-8209-8608)
- David Issadore (ORCID: https://orcid.org/0000-0002-5461-8653)
- Portia S. N. Maidment
- Michael J. Mitchell (ORCID: https://orcid.org/0000-0002-3628-2244)
- Katherine J. Mossburg (ORCID: https://orcid.org/0000-0003-1317-4061)
- Sagar Yadavali (ORCID: https://orcid.org/0000-0002-0195-4346)
- Jessica C. Hsu (ORCID: https://orcid.org/0000-0002-3599-2834)
- Emily K. Berkow
- Derick N. Rosario Berrios
- Diego Barragan
- Nathaniel H. O
Institutions
- University of Wisconsin–Madison (US)
- Cardiovascular Institute of the South (US)
- Halo Labs (United States) (US)
- Saint Joseph's University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1007/s00259-024-06967-5
- Citations
- 6
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- University of Pennsylvania
- National Nanotechnology Initiative
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering